Use of Oral Glucocorticoids and the Risk of Pulmonary Embolism

Hillier, 2007, Diamonds are forever: the cortisone legacy, J Endocrinol, 195, 1, 10.1677/JOE-07-0309 van Staa, 2000, Use of oral corticosteroids in the United Kingdom, QJM, 93, 105, 10.1093/qjmed/93.2.105 Souverein, 2004, Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study, Heart, 90, 859, 10.1136/hrt.2003.020180 Wei, 2004, Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease, Ann Intern Med, 141, 764, 10.7326/0003-4819-141-10-200411160-00007 Dekkers, 2007, Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma, J Clin Endocrinol Metab, 92, 976, 10.1210/jc.2006-2112 Etxabe, 1994, Morbidity and mortality in Cushing's disease: an epidemiological approach, Clin Endocrinol (Oxf), 40, 479, 10.1111/j.1365-2265.1994.tb02486.x Whitworth, 2005, Cardiovascular consequences of cortisol excess, Vasc Health Risk Manag, 1, 291, 10.2147/vhrm.2005.1.4.291 Albiger, 2006, Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors, Horm Metab Res, 38, 405, 10.1055/s-2006-944545 de Prada, 2007, Atherogenesis takes place in cholesterol-fed rabbits when circulating concentrations of endogenous cortisol are increased and inflammation suppressed, Atherosclerosis, 191, 333, 10.1016/j.atherosclerosis.2006.05.049 Stuijver, 2011, Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study, J Clin Endocrinol Metab, 96, 3525, 10.1210/jc.2011-1661 Heaton, 1989, Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes, Mol Endocrinol, 3, 185, 10.1210/mend-3-1-185 Huang, 1995, Effects of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cells, Blood Coagul Fibrinolysis, 6, 438, 10.1097/00001721-199507000-00011 Morange, 1999, Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue, Diabetes, 48, 890, 10.2337/diabetes.48.4.890 van Zaane, 2010, Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors, J Thromb Haemost, 8, 2483, 10.1111/j.1538-7836.2010.04034.x Gottschalk, 1993, Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations, J Nucl Med, 34, 1119 Stein, 2006, Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators, Am J Med, 119, 1048, 10.1016/j.amjmed.2006.05.060 von Elm, 2008, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, J Clin Epidemiol, 61, 344, 10.1016/j.jclinepi.2007.11.008 Bertoletti, 2012, Clinical presentation and outcome of venous thromboembolism in COPD, Eur Respir J, 39, 862, 10.1183/09031936.00058811 Stein, 2007, Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease, J Cardiovasc Med (Hagerstown), 8, 253, 10.2459/01.JCM.0000263509.35573.2c Rizkallah, 2009, Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis, Chest, 135, 786, 10.1378/chest.08-1516 Beemath, 2006, Risk of venous thromboembolism in patients hospitalized with heart failure, Am J Cardiol, 98, 793, 10.1016/j.amjcard.2006.03.064 Bernstein, 2007, Hospitalization-based major comorbidity of inflammatory bowel disease in Canada, Can J Gastroenterol, 21, 507, 10.1155/2007/924257 Nguyen, 2008, Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients, Am J Gastroenterol, 103, 2272, 10.1111/j.1572-0241.2008.02052.x Grainge, 2010, Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study, Lancet, 375, 657, 10.1016/S0140-6736(09)61963-2 Aggarwal, 2006, Inflammation and cancer: how hot is the link?, Biochem Pharmacol, 72, 1605, 10.1016/j.bcp.2006.06.029 Levitan, 1999, Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data, Medicine (Baltimore), 78, 285, 10.1097/00005792-199909000-00001 Heit, 2005, Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study, Ann Intern Med, 143, 697, 10.7326/0003-4819-143-10-200511150-00006 Niki, 2010, Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis, J Orthop Sci, 15, 57, 10.1007/s00776-009-1410-3 Matta, 2009, Risk of venous thromboembolism with rheumatoid arthritis, Thromb Haemost, 101, 134, 10.1160/TH08-08-0551 Zöller, 1994, Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis, Lancet, 343, 1536, 10.1016/S0140-6736(94)92940-8